December 01, 2021

IBRI Partners with Schrödinger to Accelerate Molecular Design and Drug Discovery

Indianapolis, Ind. - The Indiana Biosciences Research Institute (IBRI), a leading translational science institute, today announced an agreement with Schrödinger, whose physics-based software platform is transforming the way therapeutics and...

November 15, 2021

Indiana Biosciences Research Institute Selects CDD Vault to Manage Experimental Data for Translational Research

Indianapolis, Ind. - The Indiana Biosciences Research Institute (IBRI), a leading translational science institute, today announced an agreement with Collaborative Drug Discovery, Inc. (CDD) that will help it translate disease...

November 08, 2021

IBRI IN THE NEWS: Diabetes Research Connection awards $400,000 to eight promising T1D studies as nation observes National Diabetes Month

San Diego - ( Business Wire ) - Diabetes Research Connection (DRC), a 501(c)(3) that funds research projects conducted by early-career researchers aimed at prevention, cure, and better care for...

September 01, 2021

IBRI IN THE NEWS: How autoimmunity starts

When Decio Eizirik began treating patients with type 1 diabetes in the 1980s, he was pretty sure about what was behind the disease: an immune system gone haywire. People with...

August 20, 2021

IBRI RESEARCH PUBLISHED: From pancreatic ß-cell gene networks to novel therapies for type 1 diabetes

Abstract Completion of the Human Genome Project enabled a novel systems - and network-level understanding of biology, but this remains to be applied for understanding the pathogenesis of type...

August 18, 2021

IBRI RESEARCH PUBLISHED: The pancreatic ß cell response to secretory demands and adaption to stress

Abstract Pancreatic β cells dedicate much of their protein translation capacity to produce insulin to maintain glucose homeostasis. In response to increased secretory demand, β cells can compensate by...

July 29, 2021

Open House to Celebrate 1st Anniversary

You're Invited to an Open House! We look forward to celebrating the 1st anniversary of our new building with you. You'll have an opportunity to tour our research labs...

July 14, 2021

IBRI IN THE NEWS: Research round-up: autoimmune disease

Tissues' shared response to attack Type 1 diabetes, lupus, multiple sclerosis and rheumatoid arthritis can all be characterized as the immune system attacking a person’s own tissues. There are...

July 09, 2021

IBRI RESEARCH PUBLISHED: A functional genomic approach to identify reference genes for human pancreatic beta cell real-time quantitative RT-PCR analysis

Abstract Exposure of human pancreatic beta cells to pro-inflammatory cytokines or metabolic stressors is used to model events related to type 1 and type 2 diabetes, respectively. Quantitative real-time...

June 09, 2021

Insilico Medicine Collaborates with the Indiana Biosciences Research Institute

Insilico Medicine , a global leader in deep learning for drug discovery and development, is pleased to announce that it has entered into a research collaboration with the Indiana Biosciences...

 1 2 3 4 5  ... Last 
2020 Annual Report cover

The IBRI 2020 Annual Report is now available. The report theme, ‘Shaping the Future of Translational Science,’ reflects the IBRI’s commitment to turning scientific discovery into improved outcomes for patients.